<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Foods and Raw Materials</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Foods and Raw Materials</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Foods and Raw Materials</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2308-4057</issn>
   <issn publication-format="online">2310-9599</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">100579</article-id>
   <article-id pub-id-type="doi">10.21603/2308-4057-2026-2-673</article-id>
   <article-id pub-id-type="edn">GCLICJ</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Research Article</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Research Article</subject>
    </subj-group>
    <subj-group>
     <subject>Research Article</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Carcinogenesis of malignant neoplasms in cats: Development factors</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Carcinogenesis of malignant neoplasms in cats: Development factors</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1769-5043</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Kaledin</surname>
       <given-names>Anatoly P.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kaledin</surname>
       <given-names>Anatoly P.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0041-1091</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Stepanova</surname>
       <given-names>Marina V.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Stepanova</surname>
       <given-names>Marina V.</given-names>
      </name>
     </name-alternatives>
     <email>stepanova-marina@bk.ru</email>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7138-6463</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Sotnikova</surname>
       <given-names>Larisa F.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Sotnikova</surname>
       <given-names>Larisa F.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1533-8680</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Zaitsev</surname>
       <given-names>Sergei Yu.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Zaitsev</surname>
       <given-names>Sergei Yu.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9322-1464</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Melikova</surname>
       <given-names>Yulia N.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Melikova</surname>
       <given-names>Yulia N.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-5"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-6201-8250</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Kuryndina</surname>
       <given-names>Anastasia S.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kuryndina</surname>
       <given-names>Anastasia S.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-6"/>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-0921-627X</contrib-id>
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Vilmis</surname>
       <given-names>Daria A.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Vilmis</surname>
       <given-names>Daria A.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-7"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Russian State Agrarian University – Moscow Timiryazev Agricultural Academy</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian State Agrarian University – Moscow Timiryazev Agricultural Academy</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-5">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-6">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-7">
    <aff>
     <institution xml:lang="ru">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Russian Biotechnological University</institution>
     <city>Moscow</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2025-06-27T00:00:00+03:00">
    <day>27</day>
    <month>06</month>
    <year>2025</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-06-27T00:00:00+03:00">
    <day>27</day>
    <month>06</month>
    <year>2025</year>
   </pub-date>
   <volume>14</volume>
   <issue>2</issue>
   <fpage>264</fpage>
   <lpage>275</lpage>
   <history>
    <date date-type="received" iso-8601-date="2024-08-20T00:00:00+03:00">
     <day>20</day>
     <month>08</month>
     <year>2024</year>
    </date>
    <date date-type="accepted" iso-8601-date="2025-05-06T00:00:00+03:00">
     <day>06</day>
     <month>05</month>
     <year>2025</year>
    </date>
   </history>
   <self-uri xlink:href="https://jfrm.ru/en/issues/23601/23606/">https://jfrm.ru/en/issues/23601/23606/</self-uri>
   <abstract xml:lang="ru">
    <p>An effective and timely prevention of diseases in animal companions is a major task faced by the modern veterinary science. This research featured the correlation between malignant neoplasms and ophthalmological diseases in cats. The authors studied the multifactorial effect on the neoplastic proliferation and cancer-related ophthalmopathy to develop a general scheme of neoplastic proliferation in cats.&#13;
The effect of exogenous and endogenous factors on neoplastic proliferation was described based on experimental studies of numerous samples taken from 192 cats, including 67 cancer patients. The comprehensive methodological approach included anamnestic data sampling, clinical examination, examination of the pathological area, hematology, cytomorphology, and chemical-toxicological tests.&#13;
The cats with various ophthalmopathies were simultaneously diagnosed with one or more of the following cancer types: carcinoma (37.13%), squamous cell carcinoma (32.83%), lymphoma (29.85%), sarcoma (20.89%), melanoma (2.98%), and mastocytoma (1.49%).&#13;
The main factors of neoplastic proliferation included diet, care, living conditions, physical activity, stress, chronic inflammation, repeated cases, the rate of increase/decrease in clinical signs, previous therapies, etc. In most cases, the cancer-related ophthalmopathy developed as a result of tumor metabolites or as a side-effect of chemotherapy. The incidence of cancer-related ophthalmopathy increased with age.&#13;
Cancer was found to correlate with the amounts of zinc, iron, and lead in the fur. Another correlation occurred between carcinomas, especially mammary tumors, and the high copper content in the fur.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>An effective and timely prevention of diseases in animal companions is a major task faced by the modern veterinary science. This research featured the correlation between malignant neoplasms and ophthalmological diseases in cats. The authors studied the multifactorial effect on the neoplastic proliferation and cancer-related ophthalmopathy to develop a general scheme of neoplastic proliferation in cats.&#13;
The effect of exogenous and endogenous factors on neoplastic proliferation was described based on experimental studies of numerous samples taken from 192 cats, including 67 cancer patients. The comprehensive methodological approach included anamnestic data sampling, clinical examination, examination of the pathological area, hematology, cytomorphology, and chemical-toxicological tests.&#13;
The cats with various ophthalmopathies were simultaneously diagnosed with one or more of the following cancer types: carcinoma (37.13%), squamous cell carcinoma (32.83%), lymphoma (29.85%), sarcoma (20.89%), melanoma (2.98%), and mastocytoma (1.49%).&#13;
The main factors of neoplastic proliferation included diet, care, living conditions, physical activity, stress, chronic inflammation, repeated cases, the rate of increase/decrease in clinical signs, previous therapies, etc. In most cases, the cancer-related ophthalmopathy developed as a result of tumor metabolites or as a side-effect of chemotherapy. The incidence of cancer-related ophthalmopathy increased with age.&#13;
Cancer was found to correlate with the amounts of zinc, iron, and lead in the fur. Another correlation occurred between carcinomas, especially mammary tumors, and the high copper content in the fur.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>Felis catus</kwd>
    <kwd>hematology</kwd>
    <kwd>cytomorphology</kwd>
    <kwd>visual diagnostics</kwd>
    <kwd>oncological study</kwd>
    <kwd>ophthalmological study</kwd>
    <kwd>biochemistry</kwd>
    <kwd>microelement</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>Felis catus</kwd>
    <kwd>hematology</kwd>
    <kwd>cytomorphology</kwd>
    <kwd>visual diagnostics</kwd>
    <kwd>oncological study</kwd>
    <kwd>ophthalmological study</kwd>
    <kwd>biochemistry</kwd>
    <kwd>microelement</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, et al. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Proliferation. 2020;53(8):e12865. https://doi.org/10.1111/cpr.12865</mixed-citation>
     <mixed-citation xml:lang="en">Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, et al. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Proliferation. 2020;53(8):e12865. https://doi.org/10.1111/cpr.12865</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:59. https://doi.org/10.1186/s12964-020-0530-4</mixed-citation>
     <mixed-citation xml:lang="en">Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 2020;18:59. https://doi.org/10.1186/s12964-020-0530-4</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Stepanova MV, Sotnikova LF, Zaitsev SYu. Relationships between the content of micro- and macroelements in animal samples and diseases of different etiologies. Animals. 2023;13(5):852. https://doi.org/10.3390/ani13050852</mixed-citation>
     <mixed-citation xml:lang="en">Stepanova MV, Sotnikova LF, Zaitsev SYu. Relationships between the content of micro- and macroelements in animal samples and diseases of different etiologies. Animals. 2023;13(5):852. https://doi.org/10.3390/ani13050852</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ludwig L, Dobromylskyj M, Wood GA, van der Weyden L. Feline oncogenomics: What do we know about the genetics of cancer in domestic cats? Veterinary Sciences. 2022;9(10):547. https://doi.org/10.3390/vetsci9100547</mixed-citation>
     <mixed-citation xml:lang="en">Ludwig L, Dobromylskyj M, Wood GA, van der Weyden L. Feline oncogenomics: What do we know about the genetics of cancer in domestic cats? Veterinary Sciences. 2022;9(10):547. https://doi.org/10.3390/vetsci9100547</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, et al. The National Cancer Institute-American society of Clinical Oncology Cancer Trial accrual symposium: Summary and recommendations. Journal of Oncology Practice. 2013;9(6):267–276. https://doi.org/10.1200/JOP.2013.001119</mixed-citation>
     <mixed-citation xml:lang="en">Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, et al. The National Cancer Institute-American society of Clinical Oncology Cancer Trial accrual symposium: Summary and recommendations. Journal of Oncology Practice. 2013;9(6):267–276. https://doi.org/10.1200/JOP.2013.001119</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rolph KE, Cavanaugh RP. Infectious causes of neoplasia in the domestic cat. Veterinary Sciences. 2022;9(9):467. https://doi.org/10.3390/vetsci9090467</mixed-citation>
     <mixed-citation xml:lang="en">Rolph KE, Cavanaugh RP. Infectious causes of neoplasia in the domestic cat. Veterinary Sciences. 2022;9(9):467. https://doi.org/10.3390/vetsci9090467</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shishin MV, Prosekov AYu. Investigation of morphological and antimicrobial properties of intestinal tract microorganisms. Food Processing: Techniques and Technology. 2015;39(4):134−137. (In Russ.)</mixed-citation>
     <mixed-citation xml:lang="en">Shishin MV, Prosekov AYu. Investigation of morphological and antimicrobial properties of intestinal tract microorganisms. Food Processing: Techniques and Technology. 2015;39(4):134−137. (In Russ.)</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, et al. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025. https://doi.org/10.3390/cancers13092025</mixed-citation>
     <mixed-citation xml:lang="en">Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, et al. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021;13(9):2025. https://doi.org/10.3390/cancers13092025</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pham AT, van Dijk BAC, van der Valk ES, van der Vegt B, van Rossum EFC, et al. Chronic stress related to cancer incidence, including the role of metabolic syndrome components. Cancers. 2024;16(11):2044. https://doi.org/10.3390/cancers16112044</mixed-citation>
     <mixed-citation xml:lang="en">Pham AT, van Dijk BAC, van der Valk ES, van der Vegt B, van Rossum EFC, et al. Chronic stress related to cancer incidence, including the role of metabolic syndrome components. Cancers. 2024;16(11):2044. https://doi.org/10.3390/cancers16112044</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian Journal of Ophthalmology. 2020;68(9):1829–1837. https://doi.org/10.4103/ijo.IJO_786_20</mixed-citation>
     <mixed-citation xml:lang="en">Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian Journal of Ophthalmology. 2020;68(9):1829–1837. https://doi.org/10.4103/ijo.IJO_786_20</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Henry K. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Seminars in Diagnostic Pathology. 2019;36(4):204–210. https://doi.org/10.1053/j.semdp.2019.01.002</mixed-citation>
     <mixed-citation xml:lang="en">Henry K. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment. Seminars in Diagnostic Pathology. 2019;36(4):204–210. https://doi.org/10.1053/j.semdp.2019.01.002</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Naramala S, Ahmad J, Adapa S, Gavini F, Konala VM. Case series of cancer-associated retinopathy (CAR). Cureus. 2019;11(6):e4872. https://doi.org/10.7759/cureus.4872</mixed-citation>
     <mixed-citation xml:lang="en">Naramala S, Ahmad J, Adapa S, Gavini F, Konala VM. Case series of cancer-associated retinopathy (CAR). Cureus. 2019;11(6):e4872. https://doi.org/10.7759/cureus.4872</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Uemura A, Fruttiger M, d'Amore PA, de Falco S, Joussen AM, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Progress in Retinal and Eye Research. 2021;84:100954 https://doi.org/10.1016/j.preteyeres.2021.100954</mixed-citation>
     <mixed-citation xml:lang="en">Uemura A, Fruttiger M, d'Amore PA, de Falco S, Joussen AM, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Progress in Retinal and Eye Research. 2021;84:100954 https://doi.org/10.1016/j.preteyeres.2021.100954</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Thomas AS. Paraneoplastic retinopathies: An update on pathogenesis, diagnosis and management. Annals of Eye Science. 2024;9:2. https://doi.org/10.21037/aes-23-14</mixed-citation>
     <mixed-citation xml:lang="en">Thomas AS. Paraneoplastic retinopathies: An update on pathogenesis, diagnosis and management. Annals of Eye Science. 2024;9:2. https://doi.org/10.21037/aes-23-14</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Molecular vision. 2006;12:885–891.</mixed-citation>
     <mixed-citation xml:lang="en">Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Molecular vision. 2006;12:885–891.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Serrano NC, Millan P, Páez M-C. Non-HLA associations with autoimmune diseases. Autoimmunity Reviews. 2006;5(3):209–214. https://doi.org/10.1016/j.autrev.2005.06.009</mixed-citation>
     <mixed-citation xml:lang="en">Serrano NC, Millan P, Páez M-C. Non-HLA associations with autoimmune diseases. Autoimmunity Reviews. 2006;5(3):209–214. https://doi.org/10.1016/j.autrev.2005.06.009</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Liu P, Wang S, Zhang C, Li Y. Paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian dysgerminoma: A case report and literature review. Frontiers in Immunology. 2024;15:1424243. https://doi.org/10.3389/fimmu.2024.1424243</mixed-citation>
     <mixed-citation xml:lang="en">Liu P, Wang S, Zhang C, Li Y. Paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian dysgerminoma: A case report and literature review. Frontiers in Immunology. 2024;15:1424243. https://doi.org/10.3389/fimmu.2024.1424243</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis MA, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with lung adenocarcinoma: A case report. Frontiers in Immunology. 2022;8:743798. https://doi.org/10.3389/fmed.2021.743798</mixed-citation>
     <mixed-citation xml:lang="en">Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis MA, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with lung adenocarcinoma: A case report. Frontiers in Immunology. 2022;8:743798. https://doi.org/10.3389/fmed.2021.743798</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, et al. Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology. 2020;127(2):221–229. https://doi.org/10.1016/j.ophtha.2019.09.012</mixed-citation>
     <mixed-citation xml:lang="en">Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, et al. Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology. 2020;127(2):221–229. https://doi.org/10.1016/j.ophtha.2019.09.012</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Garibaldi M, Calabrò F, Merlonghi G, Pugliese S, Ceccanti M, et al. Immune checkpoint inhibitors (ICIs)-related ocular myositis. Neuromuscular Disorders. 2020;30(5):420–423. https://doi.org/10.1016/j.nmd.2020.02.013</mixed-citation>
     <mixed-citation xml:lang="en">Garibaldi M, Calabrò F, Merlonghi G, Pugliese S, Ceccanti M, et al. Immune checkpoint inhibitors (ICIs)-related ocular myositis. Neuromuscular Disorders. 2020;30(5):420–423. https://doi.org/10.1016/j.nmd.2020.02.013</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gordon L, Dinkin M. Paraneoplastic syndromes in neuro-ophthalmology. Continuum. 2019;25(5):1401–1421. https://doi.org/10.1212/CON.0000000000000788</mixed-citation>
     <mixed-citation xml:lang="en">Gordon L, Dinkin M. Paraneoplastic syndromes in neuro-ophthalmology. Continuum. 2019;25(5):1401–1421. https://doi.org/10.1212/CON.0000000000000788</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nature Reviews Clinical Oncology. 2019;16(9):535–548. https://doi.org/10.1038/s41571-019-0194-4</mixed-citation>
     <mixed-citation xml:lang="en">Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nature Reviews Clinical Oncology. 2019;16(9):535–548. https://doi.org/10.1038/s41571-019-0194-4</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Becquart O, Lacotte J, Malissart P, Nadal J, Lesage C, et al. Myasthenia gravis induced by immune checkpoint inhibitors. Journal of Immunotherapy. 2019;42(8):309–312. https://doi.org/10.1097/CJI.0000000000000278</mixed-citation>
     <mixed-citation xml:lang="en">Becquart O, Lacotte J, Malissart P, Nadal J, Lesage C, et al. Myasthenia gravis induced by immune checkpoint inhibitors. Journal of Immunotherapy. 2019;42(8):309–312. https://doi.org/10.1097/CJI.0000000000000278</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Dyulger GP, Dyulger PG, Alikhanov O, Sedletskaya ES, Latynina ES, et al. Epidemiology, risk factors and pathomorphological features of mammary tumors in cats. Bulletin of the National academy of sciences of the Republic of Kazakhstan. 2020;(6):78–84. https://doi.org/10.32014/2020.2518-1467.185</mixed-citation>
     <mixed-citation xml:lang="en">Dyulger GP, Dyulger PG, Alikhanov O, Sedletskaya ES, Latynina ES, et al. Epidemiology, risk factors and pathomorphological features of mammary tumors in cats. Bulletin of the National academy of sciences of the Republic of Kazakhstan. 2020;(6):78–84. https://doi.org/10.32014/2020.2518-1467.185</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Govoni VM, da Silva TC, Guerra JM, Pereira IVA, Queiroga FL, et al. Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma. Veterinary and Comparative Oncology. 2021;19(2):404–408. https://doi.org/10.1111/vco.12685</mixed-citation>
     <mixed-citation xml:lang="en">Govoni VM, da Silva TC, Guerra JM, Pereira IVA, Queiroga FL, et al. Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma. Veterinary and Comparative Oncology. 2021;19(2):404–408. https://doi.org/10.1111/vco.12685</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Nosalova N, Huniadi M, Ľubica H, Valenčáková A, Horňák S, et al. Canine mammary tumors: Classification, biomarkers, traditional and personalized therapies. International Journal of Molecular Sciences. 2024;25(5):2891. https://doi.org/10.3390/ijms25052891</mixed-citation>
     <mixed-citation xml:lang="en">Nosalova N, Huniadi M, Ľubica H, Valenčáková A, Horňák S, et al. Canine mammary tumors: Classification, biomarkers, traditional and personalized therapies. International Journal of Molecular Sciences. 2024;25(5):2891. https://doi.org/10.3390/ijms25052891</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhu Z, Kitano T, Morimatsu M, Ochiai K, Ishiguro-Oonuma T, et al. A highly conserved region in BRCA2 suppresses the RAD51-interaction activity of BRC repeats. Veterinary Sciences. 2023;10(2):145. https://doi.org/10.3390/vetsci10020145</mixed-citation>
     <mixed-citation xml:lang="en">Zhu Z, Kitano T, Morimatsu M, Ochiai K, Ishiguro-Oonuma T, et al. A highly conserved region in BRCA2 suppresses the RAD51-interaction activity of BRC repeats. Veterinary Sciences. 2023;10(2):145. https://doi.org/10.3390/vetsci10020145</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Granados-Soler J-L, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, et al. Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. Scientific Reports. 2022;12:17025. https://doi.org/10.1038/s41598-022-20874-5</mixed-citation>
     <mixed-citation xml:lang="en">Granados-Soler J-L, Taher L, Beck J, Bornemann-Kolatzki K, Brenig B, et al. Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. Scientific Reports. 2022;12:17025. https://doi.org/10.1038/s41598-022-20874-5</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Oh JH, Cho J-Y. Comparative oncology: Overcoming human cancer through companion animal studies. Experimental &amp; Molecular Medicine. 2023;55(4):725–734. https://doi.org/10.1038/s12276-023-00977-3</mixed-citation>
     <mixed-citation xml:lang="en">Oh JH, Cho J-Y. Comparative oncology: Overcoming human cancer through companion animal studies. Experimental &amp; Molecular Medicine. 2023;55(4):725–734. https://doi.org/10.1038/s12276-023-00977-3</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B30">
    <label>30.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Naito E, Yuki M, Hirano T, Kainuma D, Aoyama R. Prognostic utility of preoperative neutrophil-lymphocyte ratio in cats with malignant mammary tumors. Research in Veterinary Science. 2021;135:349–354. https://doi.org/10.1016/j.rvsc.2020.10.015</mixed-citation>
     <mixed-citation xml:lang="en">Naito E, Yuki M, Hirano T, Kainuma D, Aoyama R. Prognostic utility of preoperative neutrophil-lymphocyte ratio in cats with malignant mammary tumors. Research in Veterinary Science. 2021;135:349–354. https://doi.org/10.1016/j.rvsc.2020.10.015</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B31">
    <label>31.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Gastroenterology Review. 2019;14(2):89–103. https://doi.org/10.5114/pg.2018.81072</mixed-citation>
     <mixed-citation xml:lang="en">Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Gastroenterology Review. 2019;14(2):89–103. https://doi.org/10.5114/pg.2018.81072</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B32">
    <label>32.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Goodarzi E, Beiranvand R, Naemi H, Momenabadi V, Khazaei Z. Worldwide incidence and mortality of colorectal cancer and human development index (HDI): An ecological study. World Cancer Research Journal. 2019;6:e1433. https://doi.org/10.32113/wcrj_201911_1433</mixed-citation>
     <mixed-citation xml:lang="en">Goodarzi E, Beiranvand R, Naemi H, Momenabadi V, Khazaei Z. Worldwide incidence and mortality of colorectal cancer and human development index (HDI): An ecological study. World Cancer Research Journal. 2019;6:e1433. https://doi.org/10.32113/wcrj_201911_1433</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B33">
    <label>33.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124(14):2964–2973. https://doi.org/10.1002/cncr.31543</mixed-citation>
     <mixed-citation xml:lang="en">Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124(14):2964–2973. https://doi.org/10.1002/cncr.31543</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B34">
    <label>34.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhang S, Xiao X, Yi Y, Wang X, Zhu L, et al. Tumor initiation and early tumorigenesis: Molecular mechanisms and interventional targets. Signal Transduction and Targeted Therapy. 2024;9:149. https://doi.org/10.1038/s41392-024-01848-7</mixed-citation>
     <mixed-citation xml:lang="en">Zhang S, Xiao X, Yi Y, Wang X, Zhu L, et al. Tumor initiation and early tumorigenesis: Molecular mechanisms and interventional targets. Signal Transduction and Targeted Therapy. 2024;9:149. https://doi.org/10.1038/s41392-024-01848-7</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B35">
    <label>35.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Capriotti G, Piccardo A, Giovannelli E, Signore A. Targeting copper in cancer imaging and therapy: A new theragnostic agent. Journal of Clinical Medicine. 2022;12(1):223. https://doi.org/10.3390/jcm12010223</mixed-citation>
     <mixed-citation xml:lang="en">Capriotti G, Piccardo A, Giovannelli E, Signore A. Targeting copper in cancer imaging and therapy: A new theragnostic agent. Journal of Clinical Medicine. 2022;12(1):223. https://doi.org/10.3390/jcm12010223</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B36">
    <label>36.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lener MR, Scott RJ, Wiechowska-Kozłowska A, Serrano-Fernández P, Baszuk P, et al. Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2016;48(3):1056–1064. https://doi.org/10.4143/crt.2015.282</mixed-citation>
     <mixed-citation xml:lang="en">Lener MR, Scott RJ, Wiechowska-Kozłowska A, Serrano-Fernández P, Baszuk P, et al. Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2016;48(3):1056–1064. https://doi.org/10.4143/crt.2015.282</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B37">
    <label>37.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wittung-Stafshede P. A copper story: From protein folding and metal transport to cancer. Israel Journal of Chemistry. 2016;56(9–10):671–681. https://doi.org/10.1002/ijch.201600019</mixed-citation>
     <mixed-citation xml:lang="en">Wittung-Stafshede P. A copper story: From protein folding and metal transport to cancer. Israel Journal of Chemistry. 2016;56(9–10):671–681. https://doi.org/10.1002/ijch.201600019</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B38">
    <label>38.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Golovin TS, Tolkachеv VA, Everstova EA, Vanina NV. Clinic – laborantorny indicators status of cancer patients of cats. Bulletin of the Kursk State Agricultural Academy. 2017;(1):28–30. (In Russ.)</mixed-citation>
     <mixed-citation xml:lang="en">Golovin TS, Tolkachev VA, Everstova EA, Vanina NV. Clinic – laborantorny indicators status of cancer patients of cats. Bulletin of the Kursk State Agricultural Academy. 2017;(1):28–30. (In Russ.)</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B39">
    <label>39.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Mitrokhina NV. Methods of Laboratory Diagnostics. Moscow: Veterinarnyj centr patomorfologii i laboratornoj diagnostiki doktora N.V. Mitrokhinoj; 2022. 89 p.</mixed-citation>
     <mixed-citation xml:lang="en">Mitrokhina NV. Methods of Laboratory Diagnostics. Moscow: Veterinarnyj centr patomorfologii i laboratornoj diagnostiki doktora N.V. Mitrokhinoj; 2022. 89 p.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B40">
    <label>40.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pinello K, Amorim I, Pires I, Canadas-Sousa A, Catarino J, et al. Vet-OncoNet: Malignancy analysis of neoplasms in dogs and cats. Veterinary Sciences. 2022;9(10):535. https://doi.org/10.3390/vetsci9100535</mixed-citation>
     <mixed-citation xml:lang="en">Pinello K, Amorim I, Pires I, Canadas-Sousa A, Catarino J, et al. Vet-OncoNet: Malignancy analysis of neoplasms in dogs and cats. Veterinary Sciences. 2022;9(10):535. https://doi.org/10.3390/vetsci9100535</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B41">
    <label>41.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pérez-Enriquez JM, Romero-Romero L, Alonso-Morales RA, Fuentes-Pananá EM. Tumor prevalence in cats: Experience from a reference diagnostic center in Mexico City (2006–2018). Veterinaria México OA. 2020;7(4). https://doi.org/10.22201/fmvz.24486760e.2020.4.837</mixed-citation>
     <mixed-citation xml:lang="en">Pérez-Enriquez JM, Romero-Romero L, Alonso-Morales RA, Fuentes-Pananá EM. Tumor prevalence in cats: Experience from a reference diagnostic center in Mexico City (2006–2018). Veterinaria México OA. 2020;7(4). https://doi.org/10.22201/fmvz.24486760e.2020.4.837</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B42">
    <label>42.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pereira AM, Maia MRG, Fonseca AJM, Cabrita ARJ. Zinc in dog nutrition, health and disease: A review. Animals. 2021;11(4):978. https://doi.org/10.3390/ani11040978</mixed-citation>
     <mixed-citation xml:lang="en">Pereira AM, Maia MRG, Fonseca AJM, Cabrita ARJ. Zinc in dog nutrition, health and disease: A review. Animals. 2021;11(4):978. https://doi.org/10.3390/ani11040978</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B43">
    <label>43.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Enginler SO, Toydemir TSF, Ates A, Ozturk B, Erdogan O, et al. Examination of oxidative /Antioxidative status and trace element levels in dogs with mammary tumors. Bulgarian Journal of Agricultural Science. 2015;21(5):1086–1091.</mixed-citation>
     <mixed-citation xml:lang="en">Enginler SO, Toydemir TSF, Ates A, Ozturk B, Erdogan O, et al. Examination of oxidative /Antioxidative status and trace element levels in dogs with mammary tumors. Bulgarian Journal of Agricultural Science. 2015;21(5):1086–1091.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B44">
    <label>44.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Harro CC, Smedley RC, Buchweitz JP, Langlois DK. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. Journal of Veterinary Internal Medicine. 2019;33(5):2193–2199. https://doi.org/10.1111/jvim.15619</mixed-citation>
     <mixed-citation xml:lang="en">Harro CC, Smedley RC, Buchweitz JP, Langlois DK. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. Journal of Veterinary Internal Medicine. 2019;33(5):2193–2199. https://doi.org/10.1111/jvim.15619</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B45">
    <label>45.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shahrokh M, Alsultan M, Kabalan Y. The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria. Medicine. 2023;102(28):e34283. https://doi.org/10.1097/MD.0000000000034283</mixed-citation>
     <mixed-citation xml:lang="en">Shahrokh M, Alsultan M, Kabalan Y. The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria. Medicine. 2023;102(28):e34283. https://doi.org/10.1097/MD.0000000000034283</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
